Newsletter Subject

The Sanctions Are Misfiring

From

paradigmpressgroup.com

Email Address

dailyfwd@mb.paradigmpressgroup.com

Sent On

Mon, May 20, 2024 03:51 PM

Email Preheader Text

Russia Crushes the Dollar The Sanctions Are Misfiring Hi Reader, Here?s what our editors are looki

Russia Crushes the Dollar [The Daily FWD] May 20, 2024 [UNSUBSCRIBE]( The Sanctions Are Misfiring Hi Reader, Here’s what our editors are looking at today… [Click here to learn more]( News: Emily Clancy – Crussia On the occasion of President Vladimir Putin’s election to a fifth term in office, President Xi Jinping welcomed his “good neighbor, friend and partner” to Beijing this week. They pledged to intensify cooperation against U.S. ‘containment’ of their countries, as they warned of growing nuclear tensions between rival powers. “Putin noted that 90% of trade between Russia and China was settled in yuan and rubles,” Bloomberg reports. “This means we can say our trade and investments are effectively safeguarded from the influence of third countries,” Putin jabbed. As for trade between the two countries: “Driven by Russian oil and gas sales and purchases of electronics, industrial equipment and cars, Moscow’s trade with China hit a record $240 billion in 2023.” Or its equivalent in yuan and rubles… [⇒ Read More Here]( Recommended Reads: [External Advertisementt] [BREAKING - AI Drug Sells For $4 Billion]( On December 13, 2022, a Big Pharma giant quietly bought one AI-designed drug for $4 billion. That makes it the biggest deal for an AI-designed drug in history. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business... Which is why I believe this will be the biggest AI winner you never heard of. [⇒ Get the name of the stock here...while it's still a small-cap ]( [Click here to learn more]( America: Sean Ring – Are We Enjoying The Scam Yet? As I watch from afar, I wonder how Americans can take it. Seriously, American taxpayer largesse pays for untold amounts of charity, though it’s coerced from them through tax. I don’t know who said it, but he was right: the profits of capitalism pay for the follies of socialism. How do we measure such things? It seems that deficits still don’t matter to most; in fact, too many people profit from them to force the government to be fiscally responsible. [⇒ Read More Here]( [Click here to learn more]( Market: Chris Campbell – Printing Tumors for Profit One of the first major applications of bioprinted human skin is in the cosmetic industry. The team developed bioprinted human skin, which can be used to test cosmetics, eliminating the need for animal testing. Not only would this eliminate the need to torture animals, it also provides more accurate results for human applications. (Human skin, after all, behaves differently than animal tissue when exposed to various substances.) [⇒ Read More Here]( That’s all for today, we’ll be back tomorrow with what our editors were looking at this week. Email us [here](mailto:feedback@paradigmpressgroup.com) with whatever crosses your mind that you want us to cover. We look forward to hearing from you! Looking forward to your financial future, [The Daily FWD] The Daily FWD [feedback@paradigmpressgroup.com](mailto:feedback@paradigmpressgroup.com?subject=Daily FWD Feedback) Recommended Reads: [Secret Gold Back currency RUINING Biden’s plans for a digital dollar?]( [Click here to learn more]( What you see here is a completely new form of money… As we speak, it's being used as an alternative currency across the U.S. minting in places like Utah, New Hampshire and Nevada… And since it’s made out of a thinly printed sheet of REAL gold... It may be the single best way to protect your wealth from Biden’s plan for a government controlled digital dollar. That’s why, we'd like to offer to send one to you today. But since there are a limited number, I need you to respond to [this message]( by Wednesday at midnight. [⇒ Watch this short 2 minute message that explains everything here.]( [Paradigm]( ☰ ⊗ [ABOUT]( [Contact Us]( © 2024 Paradigm Press, LLC. 1001 Cathedral Street, Baltimore, MD 21201. By submitting your email address, you consent to Paradigm Press, LLC. delivering daily email issues and advertisements. To end your The Daily FWD e-mail subscription and associated external offers sent from The Daily FWD, feel free to [click here.]( Please note: the mailbox associated with this email address is not monitored, so do not reply to this message. We welcome comments or suggestions at feedback@paradigmpressgroup.com. This address is for feedback only. For questions about your account or to speak with customer service, [contact us here]( or call (844)-731-0984. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. The Daily FWD is committed to protecting and respecting your privacy. We do not rent or share your email address. Please read our [Privacy Statement.]( If you are having trouble receiving your The Daily FWD subscription, you can ensure its arrival in your mailbox by [whitelisting The Daily FWD.](

Marketing emails from paradigmpressgroup.com

View More
Sent On

13/06/2024

Sent On

13/06/2024

Sent On

13/06/2024

Sent On

13/06/2024

Sent On

13/06/2024

Sent On

13/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.